Showing 491-500 of 2254 results for "".
The Diagnosis of Functional Movement Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-diagnosis-of-functional-movement-disorder/31884/Functional movement disorder is diagnosed using positive signs, allowing a clinician to “rule-in” the diagnosis.Cluster Headache and Other Trigeminal Autonomic Cephalalgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-and-other-trigeminal-autonomic-cephalalgias/32001/Accurate and timely classification of cluster headache vs other TACs can help speed time to relief and remission in those with headache pain.Congenital Myasthenic Syndrome Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/congenital-myasthenic-syndrome-treatment/31555/Heterogeneity makes diagnosis and treatment challenging.Migraine Preventive Therapies in Development
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies-in-development/31512/The field of headache medicine is full of promise with more migraine-specific preventive therapies in development.Contemporary Challenges in the Recognition, Diagnosis, and Management of Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/contemporary-challenges-in-the-recognition-diagnosis-and-management-of-progressive-multiple-sclerosis/31974/There are many challenges associated with identifying the transition to secondary progressive multiple sclerosis.Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29171/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.Surgical Evaluation and Treatment for Genetic Epilepsies
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/surgical-evaluation-and-treatment-for-genetic-epilepsies/32053/Genetic diagnosis can be useful in guiding surgical options for genetic epilepsies.Progressive Multiple Sclerosis: Functional, Anatomic, and Biologic Tools to Assess Disability Progression and Improve Patient Outcomes
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/progressive-multiple-sclerosis-functional-anatomic-and-biologic-tools-to-assess-disability-progression-and-improve-patient-outcomes/33143/An enhanced ability to quantify multiple sclerosis disease progression is key for timely optimization of treatment and risk mitigation of worsening disability.Rapidly Progressive Dementia Caused by Neoplastic Meningitis Attributable to Melanoma
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/rapidly-progressive-dementia-caused-by-neoplastic-meningitis-attributable-to-melanoma/32116/We present a case of neoplastic meningitis, manifesting as rapidly progressive dementia, resulting from recurrent metastatic melanoma.